| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8750811 | Respiratory Investigation | 2017 | 23 Pages |
Keywords
CZPCertolizumab pegolCTLA4abataceptETNMTXAdalimumabIFXIMIDTCZNTMRTXustekinumabgolimumabPCPAnti-CCP antibodyGLMABATNFPneumocystis jirovecii pneumoniaRheumatoid arthritisAnti-cyclic citrullinated peptide antibodycytotoxic T-lymphocyte antigen 4etanerceptinterleukinInfliximabimmune-mediated inflammatory diseaseInterstitial lung diseaseAirway diseaseTocilizumabRituximabBiological agenttumor necrosis factorMethotrexateNontuberculous mycobacteriaADA
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
![Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]](/preview/png/8750811.png "First Page Preview: Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]")
Authors
Hitoshi Tokuda, Masayoshi Harigai, Hideto Kameda, Kazunori Tomono, Noboru Takayanagi, Akira Watanabe, Sadatomo Tasaka, Takafumi Suda, Kazuhiro Tateda, Junichi Kadota,